medmix AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEDX.SW research report →
Price Chart
About the company
Established in 1922 and headquartered in Zug, Switzerland, Medmix AG stands as a global leader in innovating, manufacturing, and distributing high-precision devices and services. These solutions are meticulously engineered for the controlled mixing, application, and injection of liquids across various viscosities, serving diverse healthcare, consumer, and industrial markets worldwide. The company operates through five key divisions: Dental, Drug Delivery, Surgery, Industry, and Beauty.
- CEO
- Rene Willi
- IPO
- 2021
- Employees
- 2,574
- HQ
- Baar, CH
Get TickerSpark's AI analysis on MEDX.SW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $360.77M
- P/E
- 3548.00
- Fwd P/E
- 16.90
- PEG
- -37.31
- P/S
- 0.83
- P/B
- 0.85
- EV/EBITDA
- 7.36
- Div Yield
- 1.13%
- Gross Margin
- 36.73%
- Op Margin
- 6.27%
- Net Margin
- 0.02%
- ROE
- 0.02%
- ROIC
- 2.22%
Latest fiscal year · YoY change
- Revenue
- $448.00M-7.4%
- Gross Profit
- $161.90M+1.4%
- Op Income
- $27.40M
- Net Income
- $6.40M+186.5%
- EPS
- $0.16+188.9%
- OCF Growth
- -21.7%
- FCF Growth
- -12.6%
- 52W High
- $12.36
- 52W Low
- $7.61
- 50D MA
- $8.48
- 200D MA
- $9.48
- Beta
- 0.82
- RSI (14)
- 52
- Avg Volume
- 92.06K
No earnings-call transcripts are available for MEDX.SW yet.
- Free Float
- 59.2%
- Shares Outstanding
- 40.67M
- Float Shares
- 24.06M
Held by 75 ETFs
Biggest fund positions in MEDX.SW by dollar value.
Our MEDX.SW coverage
Recent articles, reports, and earnings notes.
No research on MEDX.SW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MEDX.SW report →medmix Strengthens Profitability and Cash Flow While Advancing Growth and Efficiency Initiatives
feeds.newsfilecorp.com · Jul 23
medmix Strengthens Its Innovation Portfolio with the Launch of FleXa(TM)
feeds.newsfilecorp.com · Jul 9
medmix' Shareholders Approve All Proposals at Annual General Meeting 2026
feeds.newsfilecorp.com · Apr 16
TIME Names medmix as one of "World's Best Companies for Sustainable Growth 2026"
feeds.newsfilecorp.com · Mar 18
FY25 Results: Resilient Performance with Strong Profit Gains in Challenging Markets
feeds.newsfilecorp.com · Feb 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.